Restanza Approval Status
FDA Approved: No
Brand name: Restanza
Generic name: cethromycin
Company: Advanced Life Sciences Holdings, Inc.
Treatment for: Pneumonia
Restanza (cethromycin) is a once-a-day oral antibiotic in development as a treatment for mild-to-moderate community acquired pneumonia (CAP).
Development Status and FDA Approval Process for Restanza
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.